Rabies Diagnostics Market: Detailed Segmentation and Forecast 2023

 

Rabies Diagnostics Market Scenario

Global Rabies Diagnostics Market Growth is accounted for USD 1964 Million in 2017 and expected to register 4.36% CAGR during the forecast period (2018–2023).

Rabies is a deadly disease caused by biting of an infected rabid animal which can affect both human and animal health. Patient suffering from rabies is likely to experience fever, headache, muscle aches, loss of appetite, nausea, and tiredness.

The increasing prevalence of rabies, raising awareness related to rabies, and the increasing number of animals are expected to drive the growth of the global rabies diagnostics market during the forecast period. Moreover, rising research and development activities by non-profit organizations and aggressive strategies by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market. For instance, in May 2016, the Centers for Disease Control and Prevention(CDC) developed LN34 innovative rapid rabies test for early detection of rabies.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7796

However, high costs associated with the diagnostic, and rising vaccination may hamper the growth of the market during the assessment period.

Rabies Diagnostics Market Segmentation

The global rabies diagnostics market has been segmented on the basis of method, technology, end-user, and region.

On the basis of method, the market has been classified as a fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histologic examination, and serology tests. Also, by technology, the market has been segmented into ELISA/immunohistochemistry, chromatography techniques, PCR, and others.

Based on market has been divided into hospitals, diagnostic centers, cancer palliative care clinics, and others. By end-user hospitals are likely to register the highest CAGR owing to the rising prevalence of rabies in emerging countries during the forecast period.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The rabies diagnostics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European rabies diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The rabies diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The rabies diagnostics market in the Middle East & Africa has been segmented into the Middle East and Africa.

Rabies Diagnostics Regional Market Summary

Asia-Pacific is likely to dominate the rabies diagnostics market during the forecast period owing to the improving healthcare infrastructure, rising investments in healthcare and expansions by market players in the region. Also, countries such as India and China are considering the fastest growing region due to a government focused toward adopting new technology and the best treatment option from a developed country. According to the World Health Organization, in 2010, the healthcare expenditure of India was 3.27% of GDP, whereas, in 2015 it has 3.89% of total GDP.

The Americas are likely to be the second-largest market in the global rabies diagnostics market owing to the rising strategic alliance by major players, increasing awareness about rabies, the involvement of non-profit organization to control rabies, and well-established healthcare infrastructure. According to the American Pet Products Association’s 2017-2018 National Pet Owners Survey, Number of animals in the American region is increasing, and there were around 60.2 million dogs, and 47.1 pet cats were present in the Americas. 

The European market is expected to hold a significant share in the rabies diagnostics market. The market growth in this region can be attributed to the government funding, well-established healthcare sector, and support of the healthcare sector coupled with increasing research and development.

The market in the Middle East & Africa is expected to account for the smallest share of the global rabies diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

RABIES DIAGNOSTICS MARKET KEY PLAYERS

SOME OF THE KEY PLAYERS IN THE GLOBAL RABIES DIAGNOSTICS MARKET ARE BIO-RAD LABORATORIES, INC., MERCK KGAA, AVIVA SYSTEMS BIOLOGY CORPORATION, CREATIVE DIAGNOSTICS, DEMEDITEC DIAGNOSTICS GMBH, ABBEXA LTD., NORGEN BIOTEK CORP., BIONOTE, INC., EXPRESS BIOTECH INTERNATIONAL INC., MYBIOSOURCE.COM., AND BIOGEN TECHNOLOGIES

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/rabies-diagnostics-market-7796

Global Enteral Feeding Devices Market to Record an Exponential CAGR by 2023

 Market Highlights

The global enteral feeding devices market size held a market value of USD 2,302.4 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period. Enteral feeding is the direct delivery of nutrients into the gastrointestinal tract (GIT) via a tube which is placed into the duodenum, jejunum or stomach through mouth, nose or percutaneous route. Major factors driving the market growth are globally growing geriatric population coupled with the rising burden of chronic diseases, increasing shift from parenteral to enteral nutrition, and mounting incidence of preterm births. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. In contrast, complications associated with enteral feeding devices including inadvertent dislodgement of tubes and stringent reimbursement policies are anticipated to restrain the market growth during the next five years. Mounting technological advancement in feeding pumps such as enhanced portable pump designs with reduced risk of complications and is augmenting the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7828 

Regional Analysis

The global enteral feeding devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would command the market over the forecast period pertaining to the presence of sophisticated medical and healthcare infrastructure and market value contributors, changing lifestyle, and the rising burden of cancer, and other noncommunicable diseases (NCDs). The American Cancer Society stated that in 2018, about 9,220 new cases of colon cancer have diagnosed in the US. 

Europe would be the second-largest value contributor in the enteral feeding devices market owing to the Asia-Pacific would represent the profitable market growth during the forecast period due to growth in geriatric population, rising incidence of oral cancer, and increasing awareness about enteric feeding devices, and surging number of hospital admissions in China, India, Japan, and Australia. The World Health Organization stated that in 2018, the incidence of oral cancer was within the top three of all cancers in a few Pacific Asian countries.

The Middle East & Africa has the least share of the global enteral feeding devices market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global enteral feeding devices market has been segmented into product, age group, indication, end user, and region.

By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

On the basis of age group, the market has been divided into adults and pediatrics.

By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others.

Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).

Key Players

Some of the spearheading players in the global enteral feeding devices market are Medtronic plc, Cook Medical, B. Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Nestlé, CONMED Corporation, Moog, Inc., Halyard Health, Inc., and Vygon SA.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828

Flat Panel Detector Market – Product Development is the best strategy for market position; Forecast till 2023

 Flat Panel Detector (FPD) Market Scope

The global flat panel detector (FPD) market size is predicted to expand at 6.7% CAGR over the forecast period. Investments in digital imaging technologies for attaining accurate images of the internal body can drive the market demand. Dropping prices of digital detectors and the growing medical tourism can positively affect market growth. Developments in digital mammography with the help of FPDs can detect abnormalities in the body. This has worked well in breast cancer diagnostics and aided in storage of images in picture archiving and communication systems. In addition, lowered radiation doses associated with FPDs do not compromise with image quality in diagnosis of diseases.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7903

The huge prevalence of periodontal diseases has driven the need for FPD for cone beam computed tomography devices. According to a report by National Center for Biotechnology Information (NCBI) in 2017, dental diseases affect close to 50% of the global populace and will fuel the market demand in the coming years. Reimbursement schemes covering imaging tests can work in favor of the global FPD market.

However, the high costs of the system can hamper market growth.

Flat Panel Detector (FPD) Market Segmentation

The global flat panel detector (FPD) market has been segmented by portability, application, and end user.

By portability, the market has been segmented into fixed and portable. The portable segment had acquired the highest market share and will lead the market.

By application, the market has been segmented into dental, medical, veterinary, orthopedic, cardiac, mammogram, and others.

The market, by end user, has been segmented into hospitals and clinics and diagnostic centers.

Flat Panel Detector (FPD) Market Regional Analysis

The global flat panel detector (FPD) market has been segmented, by region, into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas is anticipated to dominate the global flat panel detector (FPD) market owing to the technological innovations, a surge witnessed in healthcare spending, access to venture capital and government funding, and increasing incidence of chronic diseases in the region has fueled the growth of the market.

Europe is expected to hold the second largest position in the global flat panel detector (FPD) market owing to the presence of prominent players such as Siemens and Philips, a well-developed healthcare sector, government support for research & development, and high healthcare expenditure. Changing user demand and partnerships between players to stave off competition from non-European players can fuel innovation in the global flat panel detector market.

APAC is anticipated to be the fastest growing region in the global flat panel detector (FPD) market owing to the growing adoption of digital radiography systems, rising disposable income levels of patients, and increasing investments in healthcare technology. Advantages over computed radiography and analogue detectors are likely to push the demand for flat panel detectors. Moreover, the requirement for digital radiography systems amid the rising pediatric population can bode well for the market.

Flat Panel Detector (FPD) Market Competitive Outlook

PerkinElmer Inc., iRay Technology, Agfa-Gevaert Group, General Electric Company, Carestream Health, New Medical Imaging Co., Ltd, Trixell, Canon Medical Systems Corporation, Imaging Dynamics Company Ltd, Varian Medical Systems, Inc., Varex Imaging Corporation, and Fujifilm Holdings America Corporation are key players of the global FPD market.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/flat-panel-detector-market-7903

Global Dental Prosthetics Market is Expected to Experience Immense Growth During 2020 – 2023

 Overview

The Global Dental Prosthetics Market is expected to register a CAGR of 5.5% and is anticipated to reach USD 5659.4 Million by 2023. Dental prosthetics are mostly in use for the improvement of damaged or deficient teeth. It improves functions as well as the appearance of teeth. It also deals with the permanent or temporary replacement of missing teeth. Dental adhesives or screws are used to fix the dental prosthesis to teeth or dental implant.

The increasing number of dental caries, increasing per capita disposable incomes in emerging markets, rising dental tourism, and growing cosmetic dentistry treatments are the major drivers propelling market growth. However, the cost of dental procedures, the grey market of dental prosthetics, and slow adoption of new technology may hinder the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2905 

Market Dynamics

Dental caries is not only prevalent in children but also adults. About 1.8 million dentists are working around the world, and over 93% of WHO member states report having less than one dentist per 1000 population. 60%-90% of the children are facing dental problems, and the majority are from developed countries. Due to changing eating habits and increasing consumption of junk food and sugar are leading to an increase in several dental patients. Additionally, rising per capita disposable incomes in emerging markets, rising dental tourism, and increasing cosmetic dentistry treatments are driving the market growth. On the other hand, the cost of dental procedures, the grey market of dental prosthetics, and slow adoption of new technology are anticipated to hamper the market growth.

Segmentation

The global dental prosthetics market has been segmented into type, diagnosis & treatment, and end user. By type, the market has been divided into denture, crown, bridges, veneer, abutment, and inlays. The global dental prosthetics market, by type of material, has been segregated into porcelain-fused-to-metal (PFM), metal, all-ceramic, and others. By end user, the market has been divided into hospitals and clinics and dental research laboratories. The hospitals and clinics segment accounted for a market value of USD 3133.8 million in 2016.  

Key Players

The prominent players in the global dental prosthetics market are Henry Schein, Inc. (US), DENTSPLY Sirona (US), 3M (US), Institut Straumann AG (Switzerland), Zimmer Biomet (US), Nobel Biocare (Switzerland), Ivoclar Vivadent AG (Liechtenstein), Osstem Implant (South Korea), Planmeca OY (Finland), and CAMLOG Biotechnologies AG (Switzerland).

Some of the key strategies followed by the players operating in the global dental prosthetics market were innovation, product development, acquisition, and expansion.

Regional Analysis

The global dental prosthetics market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global dental prosthetics market during the forecast period. This is attributed to increasing incidences of periodontal diseases and the rising consumption of junk foods. The European market for dental prosthetics is expected to be the second-largest during the forecast period. The increasing geriatric population, which is a crucial target demographic, is expected to boost the growth of the market in this region.     

Asia-Pacific is estimated to be the fastest-growing market due to rising healthcare spending by governments across developing countries and medical tourism. Moreover, a large pool of the patient population, untapped markets, and favorable government policies are likely to provide good opportunities for market players in this region. Moreover, in the Asia-Pacific region, Australia accounted for a market share of 26.8% in 2016. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access and healthcare affordability among the developing population.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-prosthetics-market-2905 

Future Growth of Lancet Market is Expected to Grow Healthy CAGR till 2024

 Globally, lancets are being utilized by patients who are affected by endocrine related complications, cardiovascular issues, and many others. Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients. The global lancet market is growing at an exponential rate and it is expected to grow at a CAGR of 11.3% during 2016 to 2022.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2078 

The increasing prevalence of diabetes and growing incidence number of contagious and non-contagious diseases has been the major factor for influencing the growth of the market. Incidence of contagious diseases is increasing rapidly on a global level. According to the WHO, it has been calculated that, infectious diseases like plaque which is also known as black death has an estimated 50 million deaths in the 14th century, this infectious disease can be a serious disease if not treated, this disease has a case fatality ratio of around 30%-60%, as of 2013 there were 783 cases worldwide which includes 126 deaths.

The global lancet market appears to be oligopolistic owing to the presence of large players active in the regional market. The market is also characterized by a reasonable degree of brand loyalty where establishing a brand name is difficult for newcomers. However, the cost involved in manufacturing setup is low to medium which discreetly comfort the new entrants to enter in the market easily.  Developments in the medical device industry are made to simplify the diagnosis, prevention, and treatment of various diseases. One of such device is lancet, which is capturing a huge market share due to its application. Safety lancets and personal lancets being the two major types of the lancets are dominating the global lancet market.

Industry Updates

June, 2016: F. Hoffmann-La Roche AG received European approval of Avastin Drug in combination with Tarceva for cancer patients with a specific type advance lung cancer.

January, 2016: Catalent Inc., a company involved in biologics announced its research collaboration with Roche on Smartag(TM) technology. Catalent claims Roche will pay Catalent an up-front fee of $1 million. Roche to provide additional research funding during the initial phase of the collaboration between these two companies. 

October, 2015: BD announced the acquisition of GenCellBio systems, an Irish biotech company that has developed proprietary technologies that address key biological analysis protocols, for an undisclosed consideration. The acquisition is expected to improve the BD’s Next Generation Sequencing line of products. 

August, 2015: Roche Holding AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholdsers $190 million upfront and up to $235 million in contingent product related milestones.

March, 2015: BD completed the acquisition of CareFusion Corporation (CareFusion) for $12.2 billion. CareFusion will operate as a wholly-owned subsidiary of BD. The acquisition is intended to enhance the medication management and patient safety solutions provided by BD. 

March, 2015: BD announced the acquisition of CRISI Medical Systems, a medical technology company focused on providing safety and delivery of IV injectable medications. The acquisition will strengthen BD’s position in addressing preventable medication errors and improve care delivery efficiencies. 

Global Lancets Market – Regional Analysis

The oligopolistic nature of the market with North America at its prime holding the largest regional share. The factors contributing to this major share include the well-established healthcare infrastructure and the high income generating end users. As of now the medical device industry is majorly established in the U.S. and Europe. But trends are showing enormous growth opportunity in Asia, wherein China will play a prominent role in both usage and development of medical devices.

Moreover, in terms of volume; manufacturers from China are anticipated to capture a large portion of the market, companies such as Guangzhou IMPROVE MEDICAL Technology Co. Ltd, SteriLance Medical (Suzhou) Inc., and others are contributing to this major portion. These companies have established their manufacturing unit worldwide.

Global Lancets Market – Competitive Analysis

Many key players involved in this market are keen in introducing new advanced safety lancets for the treatment of various contagious diseases. HTL-STREFA S.A. accounted for major market share of global lancet market, with more than 35% of market share. The large share of the company is attributed to the high demand for safety lancet globally. Moreover, this company has a strong sales and distribution network and this company also provides after sales services and help which play a major role in the satisfaction of the customers. F. Hoffmann-La Roche AG accounts for approximately 22% which can be attributed to their product the ACCU-CHEK which is one of the safety lancets having high demand in the market.

The major players in the market which have global operations of the Lancet market, and are consistently working for the development of the following technology are F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Greiner Bio One International GmbH, Improve Medical Technology Co. Ltd, Terumo Medical Corporation, Bayer Cropscience Limited, HTL-STREFA S.A, Sarstedt AG & Co and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/lancet-market-2078

Radiology Services Market to Perceive Momentous Accruals with a hefty CAGR By 2024

 The global radiology services market size accounted for USD 8,102.51 million in 2018 and is expected to register a CAGR of 10.5% during the forecast period (2019–2024).

Radiology is the technology that diagnosis and treat diseases within the human body by using medical imaging. The radiology services are served by the radiologists and experts that are qualified for performing the test and have unique postgraduate medical education in, radiation effects on the human body, radiation safety/protection, appropriate performance and interpretation of quality radiologic, and medical imaging examinations. Radiology services comprise X-Rays, computed tomography (CT), ultrasound, fusion imaging, positron emission tomography (PET), nuclear medicine, and magnetic resonance imaging (MRI). These imaging techniques should be performed after having adequate training and understanding of radiation safety and protection.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7904

The rising prevalence of the chronic disease, increasing healthcare expenditure, the emergence of thin client 3D viewers, advancement in radiology technology, rising demand for minimally invasive procedures are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, In June 2018, FDA has anticipated reclassifying some types of radiology image software analyzers from class III to class II devices for mammography breast cancer, ultrasound breast lesions, and radiograph lung nodules. This will help to reduce the regulatory burden on the medical device industry.

However, the risk of high radiation exposure associated with the devices may hamper the growth of the market during the assessment period.

Segmentation

The global radiology services market has been segmented on the basis of product type, application, technology, end user, and region.

On the basis of product type, the market has been classified as stationary digital radiology systems and portable digital radiology systems. Stationary digital radiology systems have been further segmented into stationary ceiling-mounted systems and floor-to-ceiling mounted system. Based on application, the market has been segmented into cardiovascular imaging, chest imaging, dental imaging, mammography imaging, orthopedic imaging, and others. The market, by technology, has been segmented into computed radiology and direct digital radiology. On the basis of end user, the market has been classified as hospitals, diagnostic centers, and others. The stationary digital radiology segment is expected to hold the largest market share of the radiology services market due to acceptance of stationary systems in hospitals, extensive application, and less exposure to radiation. However, portable digital radiology segment is showing the highest growth rate owing to simplicity in the workflow, low-cost, and proficiency performing complex computational tasks.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The radiology services market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European radiology services market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The radiology services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The radiology services market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Some of the key players in the global radiology services market are 4ways Healthcare Limited, Cybernet Medical Corporation, Everlight Radiology, Global Diagnostics, Medica Reporting Ltd., Onrad, Inc, Radisphere National Radiology Group Inc., RamSoft Inc., Siemens Healthcare, Telediagnostics Services Pvt. Ltd., Telemedicine Clinic, Teleradiology Solutions Inc, and Virtual Radiology (vRAD).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/radiology-services-market-7904

Detail Study on Autoinjectors Market is Projected to Grow Magnificent CAGR till 2024

 Autoinjectors Market Overview

Global Autoinjectors Market growth is expected to register a CAGR of 17.42% to reach USD 79,741 Million by 2024.

Autoinjectors are medical devices designed to deliver the dose of the drug. These are easy to use and are intended for self-administration by patients and physicians.

Autoinjectors have numerous advantages such as decreased needle phobia anxiety and maintain dose accuracy which in turn help in the growth of the market. The growing prevalence of targeted therapies, rising incidence of anaphylaxis, and the increasing number of regulatory approvals are factors responsible for market growth.  

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6311

Market Dynamics

The global autoinjectors market has been largely benefited by the rising incidence of anaphylaxis and the growing prevalence of targeted therapies. However, increased product recall and stringent regulatory policies are anticipated to restrain market growth.

Autoinjectors Market Segmentation

The disposable autoinjectors segment is expected to lead the market and register a substantial CAGR to reach USD 53,696.20 Million by the end of 2024. The increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth. Additionally, the disposable autoinjectors segment is also projected to exhibit the highest CAGR of 17.90% from 2019 to 2024.

Autoinjectors Market Key Players

The prominent players in the global autoinjectors market are Amgen Inc. (US), Becton, Dickinson and Company (US), AbbVie Inc. (US), Mylan N.V. (US), Eli Lilly and Company (US), Ypsomed (Switzerland), Owen Mumford Ltd (UK), Consort Medical (UK), SHL Group (Taiwan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel) and Antares Pharma (US).

The players operating in the global autoinjectors market are focusing on product launches, along with expanding their global footprints by entering untapped markets.   

Americas accounted for the largest market share of 40.6% in 2018, and the regional market is projected to register a CAGR of 16.60% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Indian market is projected to exhibit the highest growth rate of 18.95% during the forecast period of 2019 to 2024. 

The European market is estimated to exceed USD 24,307.74 million by 2024. The well-established healthcare infrastructure, technology advancement, and innovation in drug delivery systems, and rising prevalence of anaphylaxis incidences, diabetes, and cancer are the factors driving the growth of the autoinjectors market in the region. Germany is the major contributor to the growth of the regional market, followed by France.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/autoinjectors-market-6311